Table 2.
References | Type of study | Population (sample size) | Location | Outcomes |
---|---|---|---|---|
Cardos et al. (72) | Feasibility | Community sample of females (16) | Romania | App use and experience |
Eden et al. (73) | Pilot + Effectiveness | Clinic sample of females (100) | US | Decisional conflict and intention to screen |
Ginsburg et al. (74) | Effectiveness | Women with abnormal clinical breast examination (556) | Bangladesh | Adherence to screening |
Heo et al. (19) | Development + Effectiveness | Community sample of females (45) | Korea | Adherence to screening |
Jiao et al. (10) | Development | N/A | China | Colorimetric detection of breast cancer cells |
Keohane et al. (18) | Effectiveness | Breast clinic sample (84) | Ireland | Knowledge of risk |
Lee et al. (75) | Effectiveness + Feasibility | Community sample, Korean American women (120) | US | Knowledge and adherence to screening; app use and experience |
Lee et al. (58)* | Development | Community sample, Korean American women (14) | US | App interest and preferences |
Tewary et al. (76) | Development + Measurement | Breast cancer tissue samples (30) | India | Automated Ki67 proliferation index scoring |
Duplicate articles are indented.
US, United States.